Safeway Seeks to Dissolve Secret $350 Million Deal With Beleaguered Blood Startup Theranos The partnership, code-named project 'T-Rex,' called for Theranos blood test facilities to be built in 800 Safeway stores nationwide.

By Geoff Weiss

Opinions expressed by Entrepreneur contributors are their own.

ceiling

The Theranos walls keep tumbling down.

Yet another exposé by Wall Street Journal reporter John Carreyrou last night revealed that the beleaguered blood test startup is severing ties with California-based supermarket chain Safeway. The two had inked a deal roughly five years ago codenamed project "T-Rex," in which Safeway paid $350 million to build Theranos-anchored blood test clinics in more than 800 of its doors nationwide.

But today, as misgivings about Theranos' technology -- which purports to perform a full range of blood tests with a mere finger prick -- have reached a fever pitch, both parties are looking to dissolve the partnership, the Journal reports. As blood tests never began and the project has been inactive for more than a year, the clinics are currently being used for flu shots and other travel-related vaccines.

Related: Out For Blood: Theranos Orchestrates Bold PR Coup in the Face of Damning Allegations

While Theranos inked a partnership with Walgreens in 2013 (this partnership has also been put on pause until Theranos resolves its issues, Walgreens has said), the Safeway deal precedes this agreement as the blood startup's exclusive supermarket partner. Safeway also reportedly invested $10 million in Theranos.

On its website, Theranos called the Journal story "inaccurate, misleading and defamatory," adding that, "No amount of cynical and misleading news coverage will stop us from focusing on our mission and our goals."

There were reportedly warning signs at the outset of the deal, current and former Safeway executives told the Journal. When Theranos came to its headquarters to do blood tests on employees, for instance, one received a frighteningly high result that suggested the executive had prostate cancer. A retest by a traditional lab showed nothing abnormal.

Related: Theranos Founder Says the Company Will 'Absolutely' Get FDA Approval

Geoff Weiss

Former Staff Writer

Geoff Weiss is a former staff writer at Entrepreneur.com.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Business News

Elon Musk's DOGE Is Hiring People Eager to 'Work Long Hours' to Eliminate 'Waste, Fraud and Abuse' in the Government. Here's How to Apply.

The Department of Government Efficiency is hiring U.S. citizens to help cut spending and headcounts in the federal government.

Business News

Uber's CEO Says Drivers Have About 10 Years Left Before They Will Be Replaced

Uber CEO Dara Khosrowshahi says the jobs of human drivers are safe for the next decade, but after that, another type of driver will take over.

Branding

How to Build a Strong Brand Identity for Your Early-Stage Startup

Branding might not be your first priority, but neglecting it can hurt your startup. A strong brand identity early on sets the stage for marketing success.

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

Science & Technology

From Data to Destiny — How AI Can Turbocharge Your Business Future

Are you ready to embrace the power of AI with trusted data? Let's transform challenges into opportunities and propel your business into the future.

Business News

'Everyone Can Profit From It': What Is DeepSeek? China's 'Cheap' to Make AI Chatbot Climbs to the Top of Apple, Google U.S. App Stores

DeepSeek researchers claim it was developed for less than $6 million, a contrast to the $100 million it takes U.S. tech startups to create AI.